I have had many people with chronic Lyme describe something that sounds almost like a contradiction. Their oxygen saturation is normal. Their heart seems to be working. Their blood count may be reasonably good. Yet when they try to think clearly, climb a flight of stairs, exercise, or simply make it through a demanding day, their brain and muscles feel as though they are running out of fuel.

They often describe heaviness, brain fog, cold hands and feet, poor exercise tolerance, or the strange feeling that their body simply cannot deliver what it needs quickly enough. The laboratory numbers may look reassuring, but their lived experience is telling them something else.

One way to understand that apparent contradiction is to think about circulation as a delivery system.

Imagine that a package is being shipped across the country. It travels hundreds of miles on an interstate highway without difficulty. The truck is full of fuel. The package is intact. Everything appears to be working perfectly. But eventually that truck has to leave the interstate, travel down progressively smaller roads, turn onto the neighborhood street, and make the final delivery to your front door.

If the neighborhood streets are blocked, the fact that the interstate is open does not help very much.

The package still does not arrive.

Our circulation works in much the same way. The heart and large arteries are essential, but they are only the beginning of the journey. Oxygen, nutrients, hormones, immune cells, and many of the treatments we use eventually have to travel through microscopic blood vessels called capillaries. This is where the delivery actually occurs.

For someone with chronic Lyme, that last mile may deserve much more attention than we have traditionally given it.

Infection and Clotting Are More Connected Than Most People Realize

Most of us learned that blood clotting exists to keep us from bleeding when we cut ourselves. That is true, but it is only part of the story.

Clotting is also part of the immune response.

When the body detects an infection, it can activate platelets and create small networks of fibrin around an area of biological threat. Immune cells participate in the process as well. The purpose is sensible: slow the spread of the organism, trap it locally, and concentrate the immune response where it is needed.

Scientists call this process immunothrombosis.[1,2]

This is not a mistake made by the body. It is an ancient defense strategy.

The difficulty comes when a response designed for temporary containment does not resolve cleanly. Inflammation can continue to activate the lining of blood vessels. Platelets can remain involved. Fibrin can accumulate. The environment surrounding the smallest blood vessels can become increasingly difficult to navigate.

Now return to our delivery truck.

The interstate may still be open, but traffic has begun building on the neighborhood streets.

At some point that affects delivery.

Borrelia Has a Remarkably Intimate Relationship With the Vascular System

This becomes particularly interesting in Lyme disease because Borrelia burgdorferi has to use the vascular system to move from the site of a tick bite into the rest of the body.

Borrelia does not simply float passively through the bloodstream. Research has shown that it interacts with the endothelial cells lining blood vessels and can stimulate them to become more adhesive and inflammatory.[3] It can also bind activated platelets through receptors involved in platelet aggregation.[4]

One of the more fascinating discoveries involves a protein in our own blood called fibronectin. Under the mechanical forces created by flowing blood, Borrelia can recruit fibronectin and use it to strengthen its interaction with the blood-vessel wall.[5]

In other words, the organism is using the environment of flowing blood to help negotiate its way through the vascular system.

Then the story becomes even more interesting.

Borrelia can also bind plasminogen, part of the system our bodies normally use to break down fibrin. Once plasminogen is converted to plasmin, that enzyme can break down components of fibrin and connective tissue. Borrelia can carry this activity on its surface, potentially helping it move through extracellular matrix and into tissue.[6-8]

So we have a remarkably dynamic interaction. The host may be using clotting to contain infection, while the organism can take advantage of parts of the clot-dissolving and tissue-remodeling systems to move through the body.

This is why, in Precision Lyme Management, I call this Stealth Pathology domain Coagulation, Matrix, and Flow Dynamics rather than simply “hypercoagulation.”

The biology is moving in both directions.

Why This Could Feel Like an Energy Problem

Now imagine what happens if blood movement through some of those smallest vessels becomes less efficient.

Your pulse oximeter may still say 98 percent. That means the hemoglobin in your arterial blood is carrying plenty of oxygen. But the number on your finger does not tell us exactly how effectively blood is moving through every microscopic capillary network in your brain, muscles, peripheral nerves, or connective tissue.

The package is on the truck.

The question is whether the truck reaches the house.

This distinction matters because the tissues we depend upon most for daily function are extraordinarily sensitive to delivery. Your brain needs continuous blood flow. Your muscles need oxygen and fuel. Your mitochondria need those raw materials to make energy. Your immune system depends upon circulation to move cells and signaling molecules into tissue. Many therapies also depend on circulation for delivery.

And once the work is done, the system has to carry metabolic and inflammatory waste away again.

Flow is therefore not simply a cardiovascular issue. It sits at the intersection of energy, immunity, treatment, and recovery.

That begins to make some of the experiences people describe with chronic illness easier to understand. The problem does not always have to be a shortage of oxygen in the blood. Sometimes the more interesting question is how effectively the final delivery system is working.

Where “Microclots” Fit Into the Story

The term microclots has become increasingly familiar because of research into COVID and Long COVID. Investigators have described interactions among inflammation, endothelial dysfunction, platelets, fibrin, and immune activity that can interfere with microvascular flow.[1,2,9]

Lyme is not Long COVID, and we should not simply transplant one disease model onto another. What makes this area worth watching in Lyme is that many of the biological pieces are already present. Borrelia interacts with endothelium, platelets, fibronectin, plasminogen, and extracellular matrix. Infection activates coagulation and inflammatory pathways. Tissue perfusion and vascular regulation can change during prolonged illness.

A study that directly examined coagulation and microcirculation in tick-borne infections found the most striking abnormalities in Borrelia miyamotoi disease rather than conventional Lyme disease.[10] That is useful information because it reminds us that this is not something to assume in every person with Lyme.

For me, the important clinical idea is simpler: flow belongs on the map.

If the Last Mile Is Congested, How Might We Support It?

Once we see the problem as one of delivery rather than simply “clots,” the Functional Medicine options become more sensible.

One of the first things I think about is not a supplement at all. I think about the conditions required for blood to move well. Adequate hydration matters because blood volume matters. Electrolytes matter, particularly in someone with autonomic dysfunction or orthostatic symptoms. Adequate protein, iron, and nutritional status matter because there is little value in improving delivery if the blood itself is not carrying what the tissues require.

Movement matters too, although this has to be approached very differently in someone with limited resilience.

Muscle contraction acts as a pump for both venous blood and lymph. Increased blood flow creates healthy shear forces along the vessel wall, stimulating nitric oxide and helping vessels remain responsive. Clinical studies consistently show that regular exercise improves endothelial function.[15]

But a person with chronic Lyme cannot simply be told to exercise more. If ten minutes of activity produces a two-day crash, then ten minutes was too much for that person's current biology. The useful dose is the amount of movement that improves circulation without consuming more recovery capacity than the person has available.

Sometimes that may initially be a five-minute walk.

That still counts.

Where Nattokinase May Fit

For some patients, I also think about nattokinase.

Nattokinase is an enzyme produced during fermentation of soybeans into the traditional Japanese food natto. It has been studied in humans because of its effects on fibrin and coagulation.

In one controlled study, a single oral dose of nattokinase increased markers showing that fibrin was being broken down and changed several other components of the coagulation system.[11] Another study using nattokinase over two months found reductions in fibrinogen and clotting factors VII and VIII.[12]

Longer-term research has been less dramatic. In one trial involving relatively healthy older adults, nattokinase did not produce significant changes in several measures of vascular and coagulation health over three years.[13]

That is roughly how I view it clinically. Nattokinase is biologically active and potentially useful when fibrin turnover appears to be part of the problem. It is not a universal Lyme supplement, and it is not a magic microclot treatment.

The traditional food natto may also be useful nutritionally, although a serving of food should not be assumed to provide the standardized enzyme activity used in supplement studies.

Curcumin Approaches the Problem From Another Direction

If nattokinase makes me think about fibrin, curcumin makes me think about the blood-vessel wall itself.

Healthy blood vessels are not passive pipes. They constantly respond to what the tissues need by widening or narrowing appropriately. The endothelial cells lining those vessels are central to that process.

Human trials have found that curcumin supplementation can improve flow-mediated dilation, a measure of how well blood vessels respond to increased blood flow.[12,13]

That places curcumin in a somewhat different part of the map. Instead of primarily supporting fibrin breakdown, it may help support endothelial signaling, nitric oxide availability, and the inflammatory environment around the vessel.

For someone whose flow problem appears to involve vascular inflammation or endothelial dysfunction, that may be more relevant than simply reaching for another fibrinolytic enzyme.

Lumbrokinase Is Another Tool Worth Knowing About

Lumbrokinase belongs to the same broader conversation as nattokinase. It is a group of fibrinolytic enzymes that has been studied in humans, particularly in vascular disease and ischemic stroke.[14]

Again, I think of it as a tool rather than a protocol.

The question is never simply whether nattokinase or lumbrokinase is “good for Lyme.” The useful question is whether abnormal fibrin handling and impaired microvascular flow appear to be important in the biology of the person we are treating.

These enzymes also deserve respect. Something does not become pharmacologically trivial simply because it is called natural. A person using aspirin, warfarin, apixaban, clopidogrel, or another medication that affects coagulation needs to consider the combined effects carefully.

The Bigger Treatment Is Often the Terrain

This is one of the reasons I resist turning Functional Medicine into a supplement list.

If someone has poor microvascular flow because they are dehydrated, profoundly deconditioned, metabolically unhealthy, inflamed, anemic, and struggling with autonomic dysfunction, giving them a bottle of nattokinase while ignoring the rest of that physiology is missing the point.

I want to improve the whole delivery system rather than chase a single mechanism. 

That starts with the basics: adequate blood volume and hydration, enough movement to support circulation without exceeding recovery capacity, and better metabolic and endothelial health. If ongoing infection or another inflammatory driver is keeping the vascular system activated, that has to be addressed as well. In selected patients, tools such as nattokinase, curcumin, or lumbrokinase may have a place, but they make the most sense when they are chosen for a specific problem within the larger flow system.

That is the difference between simply treating a mechanism and understanding the physiology that produced it.

The Last Mile Matters

Come back one last time to the delivery truck.

The interstate is open. The truck has plenty of fuel. The package is sitting inside it. From a distance, the entire delivery system appears to be working.

But the neighborhood streets are congested, and the package never quite reaches the front door.

That is how I think about Microvascular Clot Formation and impaired flow within the larger Stealth Pathology map.

For the person with Lyme whose oxygen saturation looks good while their brain remains foggy and their muscles feel as though they cannot quite get what they need, it offers another way of looking at the problem.

The question may not always be whether there is enough oxygen in the blood.

The question may be whether the body's delivery system can move oxygen, nutrients, immune cells, and treatment through that last mile, and then successfully carry away what the tissue no longer needs.

Once we begin looking at the illness at that level, something that previously felt mysterious may start to become understandable.



And when the map becomes clearer, the treatment decisions usually become clearer too.

References

1. Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nature Reviews Immunology. 2013;13:34-45.
2. De Nardi AC, et al. Immunothrombosis and its underlying biological mechanisms. Hematology, Transfusion and Cell Therapy. 2023.
3. Burns MJ, Sellati TJ, Teng EI, Furie MB. Research examining Borrelia burgdorferi and activation of human vascular endothelial cells.
4. Coburn J, Leong JM, Erban JK. Integrin-mediated binding of Borrelia burgdorferi to human platelets. Proceedings of the National Academy of Sciences. 1993.
5. Niddam AF, et al. Plasma fibronectin stabilizes Borrelia burgdorferi-endothelial interactions under vascular shear stress. Proceedings of the National Academy of Sciences. 2017.
6. Hu LT, Perides G, Noring R, Klempner MS. Binding of human plasminogen to Borrelia burgdorferi. Infection and Immunity. 1995.
7. Hallström T, et al. Borrelia burgdorferi interactions with extracellular matrix proteins and plasminogen. Journal of Infectious Diseases. 2010.
8. Bernard Q, et al. Borrelia burgdorferi protein interactions critical for microbial persistence in mammals. Cellular Microbiology. 2019.
9. Kell DB, Pretorius E. Fibrinaloid microclots in Long COVID and other post-infection diseases. Biochemical Journal. 2023.
10. Platonov AE, et al. Blood coagulation and microcirculatory disorders in ixodid tick-borne borreliosis caused by Borrelia miyamotoi. PMID: 26821412.
11. Kurosawa Y, et al. A single dose of oral nattokinase potentiates thrombolysis and anticoagulation profiles. Scientific Reports. 2015.
12. Hsia CH, et al. Nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII. Nutrition Research. 2009.
13. Hodis HN, et al. Nattokinase atherothrombotic prevention study: a randomized controlled trial. Clinical Hemorheology and Microcirculation. 2021.
14. Cao YJ, et al. Oral lumbrokinase for secondary ischemic stroke prevention: a multicenter randomized clinical trial.
15. Ashor AW, et al. Exercise modalities and endothelial function: systematic review and dose-response meta-analysis. Sports Medicine. 2015.